A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
Clinical trial NCT02131064 · COMPLETED
Trial details
- NCT number
- NCT02131064
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-25
- Primary completion
- 2015-12-31
- Enrollment
- 444
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.